For this study, researchers accessed the NIH Research Portfolio Online Reporting Tools database to determine how much funding went toward research on serious healthcare-associated infections, including Staphylococcus aureus and Clostridium difficile. In addition to a major boost in funding, the researcher also discovered research on S. aureus received the greatest funding in 2009.
Despite indications that funding for antimicrobial resistance pathogens has increased, researchers found funding levels for antimicrobial resistant bacteria-related studies are lower than funding for antimicrobial resistant non-bacterial pathogens.
Related Articles on Infection Control:
Bacterial Burden on Equipment May “Rebound” After Cleaning
Study Reveals “Concerning” Disparities in Enterobacteriaceae Prevention
Alcohol Handrubs Effective But More Time Efficient Than Chlorhexidine Washing
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
